Bidder Pharmaceutical (688073.SH): Continued suspension of trading.

Gelonghui, January 20th丨Bidet Pharmaceutical (688073.SH) announced that the company is planning to acquire control of Zhuhai Weibo Investment Co., Ltd. by issuing shares to Weiwu (Suzhou) Health Industry Investment Fund (Limited Partnership) and Vivo CypressX, Co. Limited, while also proposing to raise matching funds. According to the relevant regulations of the Shanghai Stock Exchange, after the company's application, the company's Stocks will be suspended from trading starting from January 14, 2025 (Tuesday), with the original estimated suspension period not exceeding 5 trading days. As of the date of this announcement, all related parties are actively.

Gelonghui FinanceJan 20 08:48 ET

Bide Pharmatech Investing $103 Million in Zhuhai Vivo Investment JV

MT NewswiresJan 14 05:35 ET

Bid Medicine plans to implement acquisitions in three steps to indirectly acquire 100% equity of a pharmaceutical molecular block company.

① Combi-Blocks, Inc.'s main distributor in China is Allen Chemical, and its sales team representatives indicated that the agency price should not change for now. ② Regarding the reasons for this acquisition, Bid Pharmaceutical explained that it mainly aims to enhance the competitiveness of its core business, increase market share and position, strengthen product diversity, and create a coordinated effect with the existing business of the listed company, bringing new momentum to overseas business.

cls.cnJan 13 22:04 ET

Bidder Pharmaceutical (688073.SH): Weibo Investment intends to acquire 100% equity of Combi-Blocks, Inc.

Bide Pharmaceutical (688073.SH) announced that, according to the needs of the company's Global Strategy development, the company and Weiwu (Suzhou)...

Zhitong FinanceJan 13 07:31 ET

Bid Medicine (688073.SH) plans to increase its investment in the affiliated company Weibo Investment by 0.103 billion dollars.

Bide Pharmaceutical (688073.SH) announced that, according to the needs of the company's Global Strategy development, the company and Weiwu (Suzhou)...

Zhitong FinanceJan 13 07:27 ET

Bid Pharma (688073.SH): Planning to issue shares to purchase Assets. Trading suspension starts from January 14.

Bid Pharma (688073.SH) announced that the company is planning to issue shares to Weiwu (Suzhou...

Zhitong FinanceJan 13 07:23 ET